Lisa Gill
Stock Analyst at JP Morgan
(3.18)
# 1,076
Out of 5,241 analysts
150
Total ratings
47.52%
Success rate
1.34%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFST LifeStance Health Group | Maintains: Neutral | $8 → $9 | $7.65 | +17.65% | 5 | May 14, 2026 | |
| CVS CVS Health | Maintains: Overweight | $101 → $111 | $95.89 | +15.76% | 7 | May 12, 2026 | |
| MCK McKesson | Maintains: Overweight | $1,107 → $1,015 | $760.57 | +33.45% | 16 | May 8, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $33 | $19.52 | +69.06% | 5 | May 4, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $243 → $215 | $195.20 | +10.14% | 8 | May 4, 2026 | |
| AGL agilon health | Downgrades: Underweight | $21 | $81.73 | -74.31% | 4 | May 4, 2026 | |
| HUM Humana | Maintains: Neutral | $180 → $214 | $305.12 | -29.86% | 7 | May 1, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $389 → $420 | $393.85 | +6.64% | 12 | Apr 28, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $397 → $411 | $392.68 | +4.67% | 8 | Apr 28, 2026 | |
| TDOC Teladoc Health | Maintains: Neutral | $9 → $7 | $6.36 | +10.06% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $53 | $36.19 | +46.45% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.43 | - | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $319 → $330 | $250.40 | +31.79% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $417 → $419 | $257.71 | +62.59% | 4 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $15.73 | +46.22% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $22.95 | +43.79% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $23.25 | +11.83% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $285.27 | +31.45% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.72 | +29.53% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $186.61 | +1.82% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $25.87 | +15.96% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $37.48 | -51.97% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $7.12 | -29.78% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $13.95 | +100.72% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $10.10 | +78.22% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $184.99 | +113.53% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $168.64 | +10.29% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $196.66 | -28.81% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $423.00 | -21.51% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $72.72 | +14.14% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $58.27 | +68.18% | 1 | Jan 6, 2023 |
LifeStance Health Group
May 14, 2026
Maintains: Neutral
Price Target: $8 → $9
Current: $7.65
Upside: +17.65%
CVS Health
May 12, 2026
Maintains: Overweight
Price Target: $101 → $111
Current: $95.89
Upside: +15.76%
McKesson
May 8, 2026
Maintains: Overweight
Price Target: $1,107 → $1,015
Current: $760.57
Upside: +33.45%
Option Care Health
May 4, 2026
Maintains: Overweight
Price Target: $40 → $33
Current: $19.52
Upside: +69.06%
Cardinal Health
May 4, 2026
Maintains: Neutral
Price Target: $243 → $215
Current: $195.20
Upside: +10.14%
agilon health
May 4, 2026
Downgrades: Underweight
Price Target: $21
Current: $81.73
Upside: -74.31%
Humana
May 1, 2026
Maintains: Neutral
Price Target: $180 → $214
Current: $305.12
Upside: -29.86%
UnitedHealth Group
Apr 28, 2026
Maintains: Overweight
Price Target: $389 → $420
Current: $393.85
Upside: +6.64%
Elevance Health
Apr 28, 2026
Maintains: Overweight
Price Target: $397 → $411
Current: $392.68
Upside: +4.67%
Teladoc Health
Mar 13, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $6.36
Upside: +10.06%
Mar 10, 2026
Maintains: Overweight
Price Target: $50 → $53
Current: $36.19
Upside: +46.45%
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.43
Upside: -
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $250.40
Upside: +31.79%
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $257.71
Upside: +62.59%
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $15.73
Upside: +46.22%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $22.95
Upside: +43.79%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $23.25
Upside: +11.83%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $285.27
Upside: +31.45%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.72
Upside: +29.53%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $186.61
Upside: +1.82%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $25.87
Upside: +15.96%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $37.48
Upside: -51.97%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $7.12
Upside: -29.78%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $13.95
Upside: +100.72%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $10.10
Upside: +78.22%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $184.99
Upside: +113.53%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $168.64
Upside: +10.29%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $196.66
Upside: -28.81%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $423.00
Upside: -21.51%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $72.72
Upside: +14.14%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $58.27
Upside: +68.18%